Series C Funding
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15